733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy

• David Nelson,
• Christos Hatzis,
• Jimena Trillo-Tinoco,
• Evisa Gjini,
• Ana Lako,
• Michaela Bowden,
• Andrew Browne,
• Ryan Powles,
• Tai Wang,
• Christine Tauras,
• Ruben Ferrer-Luna,
• Zoe Bleicher,
• Timothy Consedine,
• Chensheng Zhou,
• Evan Kelemen,
• Anne Lewin,
• Catherine King,
• Sumit Bhattacharya,
• Harris Bell-Temin,
• Ashok Dongre,
• Kenzie Macisaac,
• Fadi Towfic,
• Benjamin Chen

Affiliations

David Nelson

Bristol-Myers Squibb, Cambridge, MA, USA

Christos Hatzis

Bristol-Myers Squibb, Cambridge, MA, USA

Jimena Trillo-Tinoco

Bristol-Myers Squibb, Cambridge, MA, USA

Evisa Gjini

Bristol-Myers Squibb, Cambridge, MA, USA

Ana Lako

Bristol-Myers Squibb, Cambridge, MA, USA

Michaela Bowden

Bristol-Myers Squibb, Cambridge, MA, USA

Andrew Browne

Bristol-Myers Squibb, Cambridge, MA, USA

Ryan Powles

Bristol-Myers Squibb, Cambridge, MA, USA

Tai Wang

Bristol-Myers Squibb, Cambridge, MA, USA

Christine Tauras

Bristol-Myers Squibb, Cambridge, MA, USA

Ruben Ferrer-Luna

Bristol-Myers Squibb, Cambridge, MA, USA

Zoe Bleicher

Bristol-Myers Squibb, Cambridge, MA, USA

Timothy Consedine

Bristol-Myers Squibb, Cambridge, MA, USA

Chensheng Zhou

Bristol-Myers Squibb, Cambridge, MA, USA

Evan Kelemen

Bristol-Myers Squibb, Cambridge, MA, USA

Anne Lewin

Bristol-Myers Squibb, Cambridge, MA, USA

Catherine King

3 The Children's Hospital at Westmead Clinical School, The Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia

Sumit Bhattacharya

Bristol-Myers Squibb, Cambridge, MA, USA

Harris Bell-Temin

Bristol-Myers Squibb, Cambridge, MA, USA

Ashok Dongre

Bristol-Myers Squibb, Cambridge, MA, USA

Kenzie Macisaac

Bristol-Myers Squibb, Cambridge, MA, USA

Fadi Towfic

Bristol-Myers Squibb, Cambridge, MA, USA

Benjamin Chen

Bristol-Myers Squibb, Cambridge, MA, USA